1. Home
  2. ACOG vs BDSX Comparison

ACOG vs BDSX Comparison

Compare ACOG & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.84

Market Cap

129.4M

Sector

N/A

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.99

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACOG
BDSX
Founded
2000
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.4M
122.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ACOG
BDSX
Price
$5.84
$14.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$18.00
$32.50
AVG Volume (30 Days)
51.4K
136.3K
Earning Date
03-26-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
$132.35
$19.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$3.75
$0.25
52 Week High
$10.88
$20.21

Technical Indicators

Market Signals
Indicator
ACOG
BDSX
Relative Strength Index (RSI) 51.99 47.32
Support Level $5.16 $6.33
Resistance Level $6.67 $20.21
Average True Range (ATR) 0.32 1.69
MACD -0.01 -0.56
Stochastic Oscillator 33.80 3.15

Price Performance

Historical Comparison
ACOG
BDSX

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: